Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - Here's Why

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc.'s stock price increased from a previous close of $4.65 to open at $4.85 on Tuesday, with recent trading volume recorded at 461 shares.
  • The company received a "hold" rating from Wall Street Zen, contributing to a consensus rating of "Hold" with an average price target set at $13.00.
  • Veradigm is a healthcare technology company specializing in solutions such as electronic health records (EHR), analytics, and population health management for healthcare organizations across several regions.
  • Five stocks we like better than Veradigm.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price gapped up before the market opened on Tuesday . The stock had previously closed at $4.65, but opened at $4.85. Veradigm shares last traded at $4.85, with a volume of 461 shares traded.

Analysts Set New Price Targets

Separately, Wall Street Zen initiated coverage on shares of Veradigm in a report on Tuesday, May 20th. They set a "hold" rating for the company. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $13.00.

View Our Latest Stock Analysis on Veradigm

Veradigm Price Performance

The stock has a fifty day simple moving average of $4.69 and a two-hundred day simple moving average of $4.61.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.